Resolution of Neuro-muscular Block in Great Obese Patients: Neostigmine vs Sugammadex

October 19, 2015 updated by: Davide Chiumello, Policlinico Hospital
It is a observational prospective study. The aim of this study is to compare neostigmine vs sugammadex in the resolution of neuro-muscular blockade in great obese patients.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Italy
      • Milan, Italy, 20122
        • Recruiting
        • Fondazione IRCC Ca' Granda - Ospedale Maggiore Policlinico
        • Contact:
        • Principal Investigator:
          • Davide Chiumello, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Great obese patients undergoing videolaparoscopic surgery

Description

Inclusion Criteria:

  • Great obese
  • Videolaparoscopic surgery

Exclusion Criteria:

  • Age under 18
  • No acceptation of informed consent
  • New York Heart Association > 2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Sugammadex
Patients treated with Sugammadex
Drug: Two different types of drug for resolution of neuro-muscular blockade
Neostigmine
Patients treated with Neostigmine
Drug: Two different types of drug for resolution of neuro-muscular blockade

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Differences in neuro-muscular block resolution time between two groups
Time Frame: up to 36 months
up to 36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Policlinico Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Actual)

March 1, 2015

Study Registration Dates

First Submitted

March 18, 2015

First Submitted That Met QC Criteria

March 24, 2015

First Posted (Estimate)

March 30, 2015

Study Record Updates

Last Update Posted (Estimate)

October 20, 2015

Last Update Submitted That Met QC Criteria

October 19, 2015

Last Verified

October 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • Policlinico 12

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Resolution of Neuromuscular Blockade

Clinical Trials on Two different types of drug for resolution of neuro-muscular blockade

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe